(14C-methyl)-L-methionine uptake in rat brain tumors before and after treatment with the protein synthesis inhibitor cycloheximide.
Autoradiographic study of (14C-methyl)-L-methionine with brain tumor bearing rats aimed at an elucidation of the mechanism of tracer accumulation in the protein synthesis of tumor. Twice as much tracer accumulated in the tumors compared as in the contralateral gray matter (nontumor region) at 90 min post intravenous injection. The protein-bound fraction of the tumors, expressed as acid-insoluble fraction (AIF), was 1.7 +/- 0.6 (mean +/- standard deviation, n = 6), significantly higher than that (0.8 +/- 0.2) of the nontumor region (p < 0.05 by the Mann-Whitney test). The tumor AIF comprised 82.3 +/- 9.2% of the total amount of the tracers accumulated in the tumors. The protein synthesis inhibitor cycloheximide reduced the tracer uptake and the AIF of the tumors to an almost same level as the nontumor region. These findings indicate that metabolic acceleration of protein synthesis may be a main reason for the high accumulation of (14C-methyl)-L-methionine in tumor.
Mineura
K
K
Neurosurgical Service, Akita University Hospital, Japan.
Sasajima
T
T
Kuwahara
N
N
Kowada
M
M
Murakami
M
M
Uemura
K
K
D000818:Animals; D001345:Autoradiography; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D002250:Carbon Radioisotopes; D003513:Cycloheximide / Q000494:pharmacology*; D008297:Male; D008715:Methionine / Q000378:metabolism*; D009363:Neoplasm Proteins / Q000096:biosynthesis*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors
D002250:Carbon Radioisotopes; D009363:Neoplasm Proteins; D003513:Cycloheximide; D008715:Methionine